Physician profile
Syed Mohsin Saghir
NPI 1225569494
$2,388.95
in general payments reported to CMS, 2019-2025
18 companies · $1,165 in 2025
The $1,165 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $56.57 · 2022: $266 · 2023: $695 · 2024: $207 · 2025: $1,165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,066.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $479.84 | 2021-2025 | Stelara, Simponi Aria, Simponi |
| Abbvie INC. | $477.68 | 2022-2025 | Skyrizi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $292.19 | 2021-2024 | Xifaxan, Trulance |
| Madrigal Pharmaceuticals | $254.57 | 2025 | Rezdiffra |
| Genzyme Corporation | $203.57 | 2022-2024 | |
| Pfizer INC. | $134.98 | 2025 | |
| Gilead Sciences, INC. | $119.58 | 2023-2024 | |
| Boston Scientific Corporation | $108.46 | 2023 | Resolution 360 Clip |
| Takeda Pharmaceuticals U.S.A., INC. | $58.60 | 2021-2023 | Entyvio |
| Amgen INC. | $53.29 | 2025 | Uplizna |
| Intercept Pharmaceuticals, INC. | $52.83 | 2023-2025 | Ocaliva |
| Celltrion USA INC. | $48.74 | 2024-2025 | Vegzelma |
| Lilly USA, LLC | $21.96 | 2024 | Omvoh |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.89 | 2024 | Cyltezo |
| Celgene Corporation | $18.50 | 2023 | Zeposia |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $17.55 | 2022 | |
| Exact Sciences Corporation | $15.17 | 2025 | Cologuard Collection Kit |
| Alexion Pharmaceuticals, INC. | $11.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Mohsin Saghir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.